Gary Bridger, EVP, Research & Development at Xenon, holds 0.00 shares in Xenon (Ticker: XENE), holds ― shares in X4 Pharmaceuticals (Ticker: XFOR), holds 0.00 shares in Neoleukin Therapeutics (Ticker: NLTX). Most recently, Gary Bridger ― shares of Xenon on ― for an estimated value of ―.